Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Protagonist Therapeutics, Inc | ptgx-20171231ex3216d0b74.htm |
| EX-31.2 - EX-31.2 - Protagonist Therapeutics, Inc | ptgx-20171231ex312549ecb.htm |
| EX-31.1 - EX-31.1 - Protagonist Therapeutics, Inc | ptgx-20171231ex31148de97.htm |
| EX-21.1 - EX-21.1 - Protagonist Therapeutics, Inc | ptgx-20171231ex211fb0584.htm |
| 10-K - 10-K - Protagonist Therapeutics, Inc | ptgx-20171231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (No. 333-213120 and No. 333-216532) and Form S-3 (No. 333-220314) of Protagonist Therapeutics, Inc. of our report dated March 7, 2018 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, CA
March 7, 2018